Tehran University of Medical Sciences

Science Communicator Platform

Share By
Synthesis, Biological Evaluation, and Molecular Docking Analysis of Novel 1,4-Naphthoquinone-Benzamides As Anti-Cancer Agents Publisher



Vosoughi Motlagh H ; Emami M ; Sayahi MH ; Negahdaripour M ; Dastyafteh N ; Ghasemi Y ; Gohari MR ; Asadi M ; Larijani B ; Mohajeritehrani MR ; Abedi M ; Pakrouh Jahromi Z ; Sajjadijazi SM ; Mahdavi M Show All Authors
Authors
  1. Vosoughi Motlagh H
  2. Emami M
  3. Sayahi MH
  4. Negahdaripour M
  5. Dastyafteh N
  6. Ghasemi Y
  7. Gohari MR
  8. Asadi M
  9. Larijani B
  10. Mohajeritehrani MR
  11. Abedi M
  12. Pakrouh Jahromi Z
  13. Sajjadijazi SM
  14. Mahdavi M
  15. Amanlou M
  16. Ranjbar S

Source: Journal of Molecular Structure Published:2026


Abstract

This study presents the synthesis of new 2-amino-1,4-naphthoquinone-N-alkyl/arylbenzamide derivatives (5a-n) and evaluates their cytotoxicity against two human cancer cells (A549 and MCF-7), as well as against normal human cells (MRC-5), using the MTT assay. Compound 5a demonstrated superior cytotoxicity compared to other derivatives against the A549 and MCF-7 cells, with IC50 values of 11.4 ± 2.7 and 13.9 ± 1.1 μM, respectively. Its anti-tumor activity was comparable to that of cisplatin. Additionally, 5a exhibited selectivity toward cancer cell lines over MRC-5 (IC50 = 72.7 ± 3.2 μM). Further investigations revealed that 5a could effectively cause cell cycle arrest at the G0/G1 phase and induce apoptosis in A549 cells. Molecular docking studies were also conducted to assess the potential interactions of 5a with the binding sites of phosphatidylinositol 3-kinase and caspase-8. These findings provide new insights for further development of naphthoquinone derivatives as anti-cancer agents. © 2025
Other Related Docs